<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39310711</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1432-2277</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Transplant international : official journal of the European Society for Organ Transplantation</Title><ISOAbbreviation>Transpl Int</ISOAbbreviation></Journal><ArticleTitle>The Relative Risk of COVID-19 in Solid Organ Transplant Recipients Over Waves of the Pandemic.</ArticleTitle><Pagination><StartPage>13351</StartPage><MedlinePgn>13351</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13351</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/ti.2024.13351</ELocationID><Abstract><AbstractText>Solid organ transplant recipients (SOTR) are at increased risk from COVID-19. Over time, the absolute risk of adverse outcomes after COVID-19 has decreased in both the non-immunosuppressed/immunocompromised (non-ISC) general population, and amongst SOTR. Using the N3C, we examined the absolute risk of mortality, major adverse renal or cardiac events, and hospitalization after COVID-19 diagnosis amongst non-ISC and SOTR populations over five waves of the pandemic (Wave 1: Ancestral COVID; Wave 2: Alpha; Wave 3: Delta; Wave 4: Omicron; Wave 5: Omicron). Within each wave, we determined the relative risk of each outcome for SOTR versus the non-ISC population based on crude event rates, and then used multivariable cox proportional hazards models and logistic regression to determine the adjusted risk of each outcome based on SOT status. Throughout the pandemic, including during the Omicron wave (Wave 5), SOTR were at greater absolute risk for each outcome than non-ISC patients (<i>p</i>-values all &lt;0.001). The adjusted risk of SOT status for each outcome was relatively stable over time (aHR 1.28-1.61 for mortality; aHR 1.31-1.47 for MACE; aHR 1.72-1.90 for MARCE; aHR 1.75-2.07 for AKI; and aOR 1.53-1.81 for hospitalization). Despite a reduction in the absolute risk of COVID-19 complications, the relative risk for SOTR versus the non-ISC population has not improved.</AbstractText><CopyrightInformation>Copyright © 2024 Vinson, Anzalone, Schissel, Dai, Agarwal, Lee, Olex and Mannon.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vinson</LastName><ForeName>Amanda J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anzalone</LastName><ForeName>Alfred J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schissel</LastName><ForeName>Makayla</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Gaurav</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Stephen B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases (Regina), University of Saskatchewan, Saskatoon, SK, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olex</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Virginia Commonwealth University, Virginia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mannon</LastName><ForeName>Roslyn B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Division of Nephology, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Transpl Int</MedlineTA><NlmUniqueID>8908516</NlmUniqueID><ISSNLinking>0934-0874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016377" MajorTopicYN="Y">Organ Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066027" MajorTopicYN="Y">Transplant Recipients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Sars-CoV-2</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">relative risks</Keyword><Keyword MajorTopicYN="N">transplant</Keyword><Keyword MajorTopicYN="N">variant strain</Keyword><Keyword MajorTopicYN="N">waves</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>17</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>17</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39310711</ArticleId><ArticleId IdType="pmc">PMC11413870</ArticleId><ArticleId IdType="doi">10.3389/ti.2024.13351</ArticleId><ArticleId IdType="pii">13351</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vnson AJ, Agarwal G, Dai R, Anzalone AJ, Lee SB, French E, et al. COVID-19 in Solid Organ Transplantation: Results of the National COVID Cohort Collaborative. Transpl Direct (2021) 7(11):e775. 10.1097/TXD.0000000000001234</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TXD.0000000000001234</ArticleId><ArticleId IdType="pmc">PMC8500600</ArticleId><ArticleId IdType="pubmed">34646938</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias M, Pievani D, Randoux C, Louis K, Denis B, Delion A, et al. COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes. J Am Soc Nephrol (2020) 31(10):2413–23. 10.1681/ASN.2020050639</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020050639</ArticleId><ArticleId IdType="pmc">PMC7609004</ArticleId><ArticleId IdType="pubmed">32847984</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. COVID-19 in Solid Organ Transplant Recipients: Initial Report From the US Epicenter. Am J Transpl (2020) 20(7):1800–8. 10.1111/ajt.15941</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.15941</ArticleId><ArticleId IdType="pmc">PMC7264777</ArticleId><ArticleId IdType="pubmed">32330343</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinson AJ, Anzalone AJ, Sun J, Dai R, Agarwal G, Lee SB, et al. The Risk and Consequences of Breakthrough SARS-CoV-2 Infection in Solid Organ Transplant Recipients Relative to Non-Immunosuppressed Controls. Am J Transpl (2022) 22(10):2418–32. 10.1111/ajt.17117</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.17117</ArticleId><ArticleId IdType="pmc">PMC9348256</ArticleId><ArticleId IdType="pubmed">35674237</ArticleId></ArticleIdList></Reference><Reference><Citation>Nab L, Parker EPK, Andrews CD, Hulme WJ, Fisher L, Morley J, et al. Changes in COVID-19-Related Mortality Across Key Demographic and Clinical Subgroups in England From 2020 to 2022: A Retrospective Cohort Study Using the OpenSAFELY Platform. Lancet Public Health (2023) 8(5):e364–e377. 10.1016/S2468-2667(23)00079-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(23)00079-8</ArticleId><ArticleId IdType="pmc">PMC10139026</ArticleId><ArticleId IdType="pubmed">37120260</ArticleId></ArticleIdList></Reference><Reference><Citation>Solera JT, Arbol BG, Mittal A, Hall V, Marinelli T, Bahinskaya I, et al. Longitudinal Outcomes of COVID-19 in Solid Organ Transplant Recipients From 2020 to 2023. Am J Transpl (2024) 24:1303–16. 10.1016/j.ajt.2024.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2024.03.011</ArticleId><ArticleId IdType="pubmed">38499087</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, Eichmann DA, Guinney J, Kibbe WA, et al. The National COVID Cohort Collaborative (N3C): Rationale, Design, Infrastructure, and Deployment. J Am Med Inform Assoc (2021) 28(3):427–43. 10.1093/jamia/ocaa196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett TD, Moffitt RA, Hajagos JG, Amor B, Anand A, Bissell MM, et al. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative. JAMA Netw Open (2021) 4(7):e2116901. 10.1001/jamanetworkopen.2021.16901</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16901</ArticleId><ArticleId IdType="pmc">PMC8278272</ArticleId><ArticleId IdType="pubmed">34255046</ArticleId></ArticleIdList></Reference><Reference><Citation>
GitHub. National-COVID-Cohort-Collaborative/Phenotype_Data_Acquisition (2021). Available from: https://github.com/National-COVID-Cohort-Collaborative/Phenotype_Data_Acquisition (Accessed March 17, 2021).</Citation></Reference><Reference><Citation>Sun J, Zheng Q, Madhira V, Olex AL, Anzalone AJ, Vinson A, et al. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US. JAMA Intern Med (2022) 182(2):153–62. 10.1001/jamainternmed.2021.7024</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.7024</ArticleId><ArticleId IdType="pmc">PMC8715386</ArticleId><ArticleId IdType="pubmed">34962505</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinson AJ, Dai R, Agarwal G, Anzalone AJ, Lee SB, French E, et al. Sex and Organ-Specific Risk of Major Adverse Renal or Cardiac Events in Solid Organ Transplant Recipients With COVID-19. Am J Transpl (2022) 22(1):245–59. 10.1111/ajt.16865</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16865</ArticleId><ArticleId IdType="pmc">PMC8653020</ArticleId><ArticleId IdType="pubmed">34637599</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall VG, Solera JT, Al-Alahmadi G, Marinelli T, Cardinal H, Poirier C, et al. Severity of COVID-19 Among Solid Organ Transplant Recipients in Canada, 2020–2021: A Prospective, Multicentre Cohort Study. Can Med Assoc J (2022) 194(33):E1155–E1163. 10.1503/cmaj.220620</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.220620</ArticleId><ArticleId IdType="pmc">PMC9435532</ArticleId><ArticleId IdType="pubmed">36302101</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke JA, Wiemken TL, Korenblat KM. Excess Mortality Among Solid Organ Transplant Recipients in the United States During the COVID-19 Pandemic. Transplantation (2022) 106(12):2399–407. 10.1097/TP.0000000000004341</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004341</ArticleId><ArticleId IdType="pmc">PMC9696767</ArticleId><ArticleId IdType="pubmed">36042551</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>